Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline effects on perception and consciousness in healthy volunteers
NL-OMON46867Active, not recruiting
- Sponsor
- University of Amsterdam
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of cabergoline (2 arms), sponsored by University of Amsterdam. Primary endpoints: Task performance, Electroencephalographic measures and 1 more. Started Jan 2018; status: active, not recruiting.
02
Drugs
cabergoline
Beyond the preview
Go deeper on NL-OMON46867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46867.